Neuron‐specific age‐related decreases in dopamine receptor subtype mRNAs
- 31 December 2002
- journal article
- research article
- Published by Wiley in Journal of Comparative Neurology
- Vol. 456 (2) , 176-183
- https://doi.org/10.1002/cne.10525
Abstract
Age‐related decline in dopamine receptor levels has been observed in regional studies of animal and human brains; however, identifying specific cellular substrates and/or alterations in distinct neuronal populations remains elusive. To evaluate whether age‐related decreases in dopamine receptor subtypes are associated with specific cell populations in the hippocampus and entorhinal cortex, antisense RNA amplification was combined with cDNA array analysis to examine effects of aging on D1–D5 dopamine receptor mRNA expression levels in hippocampal CA1 pyramidal neurons and entorhinal cortex layer II stellate cells from post‐mortem human brains (19–92 years). In CA1 pyramidal neurons, significant age‐related decline was observed for dopamine receptor mRNAs (D1–D4, P < 0.001; D5, P < 0.05) but not for the cytoskeletal elements β‐actin, three‐repeat (3R) tau, and four‐repeat (4R) tau. In contrast, no significant changes were observed in stellate cells across the same cohort. Thus, senescence may be a factor responsible for cell‐specific decrements in dopamine receptor gene expression in one population of neurons within a circuit that is critical for learning and memory. Furthermore, these results support the hypothesis that alterations in dopaminergic function may also be related to behavioral abnormalities, such as psychosis, that occur with aging. J. Comp. Neurol. 456:176–183, 2003.Keywords
This publication has 62 references indexed in Scilit:
- Genetic or pharmacological inactivation of the dopamine D1 receptor differentially alters the expression of regulator of G‐protein signalling (Rgs) transcriptsEuropean Journal of Neuroscience, 2006
- Age-related dopamine D2/D3 receptor loss in extrastriatal regions of the human brainNeurobiology of Aging, 2000
- Selective changes in the contents of noradrenaline, dopamine and serotonin in rat brain areas during agingJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1999
- Aging and the brain: A new frontierAnnals of Neurology, 1997
- Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in alzheimer's diseaseJournal of Comparative Neurology, 1994
- Dopamine D2 Receptors in Normal Human Brain: Effect of Age Measured by Positron Emission Tomography (PET) and [11C]‐RacloprideaAnnals of the New York Academy of Sciences, 1993
- Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]RacloprideJournal of Cerebral Blood Flow & Metabolism, 1993
- AGEING AND PARKINSON'S DISEASE: SUBSTANTIA NIGRA REGIONAL SELECTIVITYBrain, 1991
- Human brain dopamine receptors in children and aging adultsSynapse, 1987
- Prevalence of abnormal involuntary movements (?spontaneous dyskinesias?) in the normal elderlyPsychopharmacology, 1982